An Israeli study offers new hope for prostate cancer patients
Prostate cancer is the most common tumor in men, and in a third of cases the disease will return even after treatment.
Now an Israeli study has found a drug that significantly lowers the risk of recurrence of the disease
Walla!
health
13/12/2021
Monday, 13 December 2021, 12:08 Updated: 12:16
Share on Facebook
Share on WhatsApp
Share on Twitter
Share on Email
Share on general
Comments
Comments
Almost every man over the age of 40 suffers from benign prostate enlargement, which is manifested by difficulty urinating or an increase in the frequency of urination - especially at night.
Most men ignore these symptoms (although there is a way to treat them), and this can be a problem - as in some cases the exact same symptoms can be a sign of prostate cancer.
More on Walla!
Getting up for the bathroom in the middle of the night?
You should read this
To the full article
Prostate cancer is the most common cancer among men in Israel, every year about 2,500 new cases of this cancer are discovered in Israel, usually among men aged 50 and over.
In most cases, survival rates from the disease are high - over 90 percent - largely due to early detection.
However, there are cases where the tumor is more aggressive, and in these cases the mortality rates are high.
And as with almost any cancer, there is always the danger that the disease will return even after healing.
In a third of patients the disease recurs
Now, a new Israeli study, led by Dr. Daniel Keisman, director of the urinary tract tumor unit at the Ichilov Oncology Division, shows promising results in treating prostate cancer patients in case of recurrence of non-metastatic disease.
"Prostate cancer is the most common tumor in men in the Western world. Recurrence of the disease after initial treatment with surgery or radiation, "explains Dr. Keisman," When recurrence of the disease is manifested by an increase in the PSA marker without metastases - there is currently no proven treatment. "
To date there has been no treatment for non-metastatic recurrent disease.
Illustration of prostate cancer (Photo: ShutterStock)
More on Walla!
The ingredient in food that causes cancer to spread much faster
Researchers have discovered what happens in the bodies of cancer patients just before the metastases
How much does it cost to treat pain and what is the cheapest solution that is also the most effective?
The new study he published showed promising results for the treatment with factsol - a natural substance that inhibits the protein galactin 3, which is involved in the tumor process and the recurrence of prostate cancer.
"Compared to the course of the disease without treatment where most patients (about 80 percent) show worsening of the disease indices within six months, in a published study, it was shown that treatment with Factol resulted in disease stabilization in 78 percent, ie - only 22% showed disease progression."
The results of the study were published in the prestigious journal NUTRIENTS, and a larger phase 3 study is planned to begin soon.
health
news
Tags
cancer
prostate
Ichilov
